Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population
Global burden of breast cancer is expected to increase to >2 million new cases every year by 2030 and 10% of these are likely to have hereditary breast and ovarian cancer syndrome. Identifying these individuals by pedigree and BRCA1/2 mutation analyses will enable us to offer targeted mutation te...
Main Authors: | Mina Darooei, Subhadra Poornima, Bibi Umae Salma, Gayatri R Iyer, Akhilesh N Pujar, Srirambhatla Annapurna, Ashwin Shah, Srinivas Maddali, Qurratulain Hasan |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-02-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317694303 |
Similar Items
-
Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
by: Kendra-Ann I. Seenandan-Sookdeo, et al.
Published: (2010-07-01) -
BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
by: Ingrid Petroni Ewald, et al.
Published: (2016-06-01) -
Hereditary Breast Cancer in Latvia: Mutation Analysis of the BRCA1 Gene
by: L. Tihomirova, et al.
Published: (1999-01-01) -
The role of BRCA1/2 in hereditary and familial breast and ovarian cancers
by: Yousef M. Hawsawi, et al.
Published: (2019-09-01) -
BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer
by: Solyom, S. (Szilvia)
Published: (2011)